MedPath

Autologous Serum Skin Test and Serum IL-18 Levels in Chronic Idiopathic Urticaria and Respiratory Allergic Diseases

Completed
Conditions
Urticaria
Respiratory Allergic Diseases
Interventions
Procedure: autologous serum skin test, serum IL-18
Registration Number
NCT01091402
Lead Sponsor
Eskisehir Osmangazi University
Brief Summary

One of the proposed mechanisms in CU is autoimmunity. It was shown by a positive response to autologous serum skin test (ASST)in almost half of chronic urticaria (CU) patients. IL-18 also play a role in autoimmune disorders. The investigators aim was to investigate the relationship of ASST and IL-18 in CU and respiratory allergic diseases.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • adult patients
  • chronic urticaria patients
  • stable asthma patients
  • allergic rhinitis patients with sensitized to pollens
  • normal controls without atopic and skin disease.
Exclusion Criteria
  • unwillingness to the study
  • other dermatological problems that could affect the skin test
  • use of antihistamine drugs

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
seasonal allergic rhinitisautologous serum skin test, serum IL-18-
normal controlsautologous serum skin test, serum IL-18-
asthmaautologous serum skin test, serum IL-18-
chronic urticariaautologous serum skin test, serum IL-18-
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Eskisehir Osmangazi University

🇹🇷

Eskisehir, Turkey

© Copyright 2025. All Rights Reserved by MedPath